These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19403630)

  • 1. The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: meta-analysis of clinical trials.
    Miller ER; Juraschek SP; Appel LJ; Madala M; Anderson CA; Bleys J; Guallar E
    Am J Clin Nutr; 2009 Jun; 89(6):1937-45. PubMed ID: 19403630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive agents for treating IgA nephropathy.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 fatty acid addition during pregnancy.
    Middleton P; Gomersall JC; Gould JF; Shepherd E; Olsen SF; Makrides M
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD003402. PubMed ID: 30480773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of ω-3 polyunsaturated fatty acid interventions during pregnancy on obesity measures in the offspring: an up-to-date systematic review and meta-analysis.
    Vahdaninia M; Mackenzie H; Dean T; Helps S
    Eur J Nutr; 2019 Oct; 58(7):2597-2613. PubMed ID: 30251019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polyunsaturated fatty acid balance in kidney health and disease: A review.
    Syren ML; Turolo S; Marangoni F; Milani GP; Edefonti A; Montini G; Agostoni C
    Clin Nutr; 2018 Dec; 37(6 Pt A):1829-1839. PubMed ID: 29254659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of n-3 long-chain polyunsaturated fatty acid supplementation on biomarkers of kidney injury in adults with diabetes: results of the GO-FISH trial.
    Miller ER; Juraschek SP; Anderson CA; Guallar E; Henoch-Ryugo K; Charleston J; Turban S; Bennett MR; Appel LJ
    Diabetes Care; 2013 Jun; 36(6):1462-9. PubMed ID: 23275364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longchain polyunsaturated fatty acid supplementation in preterm infants.
    Moon K; Rao SC; Schulzke SM; Patole SK; Simmer K
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD000375. PubMed ID: 27995607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-chain polyunsaturated fatty acid supplementation in preterm infants.
    Simmer K; Schulzke SM; Patole S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD000375. PubMed ID: 18253973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long chain polyunsaturated fatty acid supplementation in infants born at term.
    Jasani B; Simmer K; Patole SK; Rao SC
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD000376. PubMed ID: 28281303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal prenatal and/or postnatal n-3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood.
    Gunaratne AW; Makrides M; Collins CT
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010085. PubMed ID: 26197477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between Long Chain n-3 Polyunsaturated Fatty Acids and Autism Spectrum Disorder: Systematic Review and Meta-Analysis of Case-Control and Randomised Controlled Trials.
    Mazahery H; Stonehouse W; Delshad M; Kruger MC; Conlon CA; Beck KL; von Hurst PR
    Nutrients; 2017 Feb; 9(2):. PubMed ID: 28218722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-chain polyunsaturated fatty acid supplementation in infants born at term.
    Simmer K; Patole SK; Rao SC
    Cochrane Database Syst Rev; 2008 Jan; (1):CD000376. PubMed ID: 18253974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longchain polyunsaturated fatty acid supplementation in preterm infants.
    Simmer K; Patole S
    Cochrane Database Syst Rev; 2004; (1):CD000375. PubMed ID: 14973956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development.
    Delgado-Noguera MF; Calvache JA; Bonfill Cosp X; Kotanidou EP; Galli-Tsinopoulou A
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD007901. PubMed ID: 26171898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of maternal n-3 long-chain polyunsaturated fatty acid supplementation during pregnancy and/or lactation on adiposity in childhood: a systematic review and meta-analysis of randomized controlled trials.
    Stratakis N; Gielen M; Chatzi L; Zeegers MP
    Eur J Clin Nutr; 2014 Dec; 68(12):1277-87. PubMed ID: 25117991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 fatty acid supplementation as an adjunctive therapy in the treatment of chronic kidney disease: a meta-analysis.
    Hu J; Liu Z; Zhang H
    Clinics (Sao Paulo); 2017 Jan; 72(1):58-64. PubMed ID: 28226034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis.
    Inker LA; Heerspink HJL; Tighiouart H; Chaudhari J; Miao S; Diva U; Mercer A; Appel GB; Donadio JV; Floege J; Li PKT; Maes BD; Locatelli F; Praga M; Schena FP; Levey AS; Greene T
    Am J Kidney Dis; 2021 Sep; 78(3):340-349.e1. PubMed ID: 33775708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
    Ruggenenti P; Perna A; Gherardi G; Benini R; Remuzzi G
    Am J Kidney Dis; 2000 Jun; 35(6):1155-65. PubMed ID: 10845831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.